HSDT Helius Medical: Accounting Book Value Bawat Bahagi

Helius Medical Technologies (HSDT) - korporatibong logo

Mayroon bang potensyal ang Helius Medical (HSDT) dahil sa promosyon ng PoNS system para labanan ang multiple sclerosis? Ang book value bawat common share ay tumutulong sa pagtatasa ng mga tunay na asset, kung saan ang markang 2.87 ay sumasalamin sa pinakabagong datos. Ang matatag na demand para sa mga portable neurostimulator ay lumilikha ng predictable na kita. Ang estratehiya ay nakasalalay sa mga partnership sa mga klinika upang ipatupad ang restorative therapy.

Stockholders Equity Bawat Bahagi Helius Medical Technologies Inc. (HSDT): para sa panahong 04.07.2022 - 27.10.2026

Helius Medical Technologies, Inc. - mga analytical breakdown at pangunahing sukatan (HSDT)

- presyo at pagtataya ng pinagkasunduang presyo:
Presyo ng Stock Helius Medical Technologies Inc.|HSDT - Pinagsamang Pagtataya ng mga Investment Firm
- datos sa market capitalization:
Pagtatasa ng Merkado Helius Medical Technologies, Inc.|HSDT - Kabuuang Halaga ng Negosyo
- datos sa book capitalization:
Netong Asset Bawat Isang Bahagi Helius Medical Technologies|HSDT - Accounting Capitalization|Ratio ng Market Capitalization sa Book Value heliusmedical.com|HSDT - Mga Asset ng Kumpanya
- datos sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity Helius Medical|HSDT - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Helius Medical Technologies Inc.|HSDT - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Helius Medical Technologies, Inc.
Fundamental valuation ng kumpanya:heliusmedical.com, HSDT
Mga produktong ginagawa ng Helius Medical Technologies Inc.

Para sa Helius Medical (HSDT), ang bps metric ay sumasalamin sa net asset value bawat siyer, na nagsisilbing indikasyon ng intrinsic stability habang isinasagawa ang komersyalisasyon ng mga neurostimulator. Ang trend ng bps ay nagpapakita ng puwang sa pagitan ng tunay na kapital at ng presyo sa merkado, na nagpapatunay ng sapat na liquidity cushion para sa pagpapaunlad ng negosyo habang naghihintay ng pag-apruba ng mga insurance reimbursement.

Mga kakumpitensya ng Helius Medical (HSDT)

Biogen Corp (BIIB) - Book Value Bawat Bahagi|Neurocrine Corp (NBIX) - Stockholders Equity Bawat Bahagi|RGC - Accounting Book Value Bawat Bahagi|AXSM (axsome.com) - Book Price ng Bahagi|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc. (ACAD)|Stockholders Equity Bawat Bahagi Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Supernus Corp SUPN|Accounting Book Value Bawat Bahagi CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi AMLX|Trevi Corp (TRVI) - Net Asset Value Bawat Bahagi|PRAX - Book Value Bawat Bahagi|Accounting Value ng Bahagi anavex.com|CeriBell - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi PRTA (Prothena Corporation)|Netong Asset Bawat Isang Bahagi Alector ALEC|Netong Asset Bawat Isang Bahagi Annexon Biosciences Inc. ANNX|Book Value Bawat Bahagi OMER (Omeros Corp.)|neurogene.com (NGNE) - Net Assets Bawat Bahagi|ACIU: Accounting Book Value Bawat Bahagi|VYGR (Voyager Therapeutics Inc) - Book Value Bawat Bahagi|NMRA: Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Accounting Book Value Bawat Bahagi|Accounting Value ng Bahagi ACOG (alphacognition.com)|Cognition Therapeutics - Netong Asset Bawat Isang Bahagi|Accounting Book Value Bawat Bahagi Inhibikase Therapeutics Inc IKT|SAVA (Cassava) - Book Value Bawat Bahagi|ASRT - Net Asset Value Bawat Bahagi|Book Value Bawat Bahagi coyatherapeutics.com|Vistagen (VTGN) - Stockholders Equity Bawat Bahagi|OVID: Book Value Bawat Bahagi|Net Assets Bawat Bahagi Acumen Pharmaceuticals Inc.|Book Value Bawat Bahagi CRVO (CervoMed Inc)|Accounting Book Value Bawat Bahagi alteritytherapeutics.com (ATHE)|Book Value Bawat Bahagi CLNN (Clene)|PepGen Inc - Book Value Bawat Bahagi|JUNS - Netong Asset Bawat Isang Bahagi|RLMD - Netong Asset Bawat Isang Bahagi|Book Value Bawat Bahagi Annovis Bio Corp ANVS|GRCE (Grace Therapeutics) - Accounting Value ng Bahagi|AIFF: Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi ANEW Medical, Inc.|Book Value Bawat Bahagi NeuroSense Therapeutics NRSN|Stockholders Equity Bawat Bahagi Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Book Value Bawat Bahagi MetaVia (MTVA)|NeurAxis Inc - Book Price ng Bahagi|Passage Bio Corp (PASG) - Netong Asset Bawat Isang Bahagi|NEUP - Stockholders Equity Bawat Bahagi|Book Value Bawat Bahagi NERV|Net Asset Value Bawat Bahagi Athira Pharma Inc|ADXN (Addex Therapeutics, Ltd.) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi ALZN|Cyclerion Therapeutics (CYCN) - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi PTIX (protagenic.com)|KTTA: Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi Cortigent Inc CRGT|Book Value Bawat Bahagi Avenue Therapeutics, Inc (ATXI)|BCLI - Accounting Value ng Bahagi|Book Value Bawat Bahagi CARA|CHRO (chromocell.com) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Eliem Therapeutics, Inc.|Netong Asset Bawat Isang Bahagi Intra-Cellular|LBPH (Longboard Pharma) - Book Value Bawat Bahagi|Net Assets Bawat Bahagi Marinus Pharma MRNS|Accounting Book Value Bawat Bahagi NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi SAGE (Sage Therapeutics)|Synaptogenix Inc. (SNPX) - Net Assets Bawat Bahagi|Accounting Book Value Bawat Bahagi Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi WENA|Accounting Book Value Bawat Bahagi cerevel.com